Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Trade Show

Abiomed to Present at the 31st Annual Piper Jaffray Healthcare Conference


Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support technologies, today announced that Michael R. Minogue, Chairman, President and Chief Executive Officer, will present at the 31st Annual Piper Jaffray Healthcare Conference on Wednesday, December 4, 2019 at 3:00pm ET. The conference will be held at the Lotte New York Palace, New York, NY.

ABOUT ABIOMED

Based in Danvers, Massachusetts, Abiomed, Inc. is a leading provider of medical devices that provide circulatory support. Our products are designed to enable the heart to rest by improving blood flow and/or performing the pumping of the heart. For additional information, please visit: www.abiomed.com

FORWARD-LOOKING STATEMENTS

This release contains forward-looking statements, including statements regarding development of Abiomed's existing and new products, the Company's progress toward commercial growth, and future opportunities and expected regulatory approvals. The Company's actual results may differ materially from those anticipated in these forward-looking statements based upon a number of factors, including uncertainties associated with development, testing and related regulatory approvals, including the potential for future losses, complex manufacturing, high quality requirements, dependence on limited sources of supply, competition, technological change, government regulation, litigation matters, future capital needs and uncertainty of additional financing, and other risks and challenges detailed in the Company's filings with the Securities and Exchange Commission, including the most recently filed Annual Report on Form 10-K and Quarterly Report on Form 10-Q. Readers are cautioned not to place undue reliance on any forward-looking statements, which speak only as of the date of this release. The Company undertakes no obligation to publicly release the results of any revisions to these forward-looking statements that may be made to reflect events or circumstances that occur after the date of this release or to reflect the occurrence of unanticipated events.


These press releases may also interest you

at 16:13
Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  On Thursday, the FDA provided information on how to safely charge hearing aids, glucose monitors, insulin pumps, and other medical...

at 16:10
JanOne Inc. announced today that it has executed a Definitive Agreement to acquire blockchain financial technology provider, ALT 5 Sigma Inc., a Delaware corporation, and each of its wholly-owned subsidiaries. The transaction is anticipated to close...

at 16:06
Amidst the excitement of Career and Technical Education (CTE) Signing Day, where students graduating from Capital Region BOCES CTE programs are matched with employers across the Capital Region, the National Institute for Innovation and Technologytm...

at 16:05
Scribe Therapeutics Inc. (Scribe), a genetic medicines company unlocking the potential of CRISPR to transform human health, presented data on its X-Editor (XE) and Epigenetic Long-Term X-Repressor (ELXR) technologies at the 27th American Society of...

at 15:39
Despite some media reports claiming otherwise, ValveTech Inc. did not call for NASA to permanently stop the Starliner launch. The company's president warned of safety concerns that need to be addressed before retrying the launch. "Some media outlets...

at 15:30
Vibrant Wellness, a CLIA-certified and CAP-accredited biotechnology company based in Santa Clara, CA, proudly announced their expansion in the UK.Vibrant is known for their extensive selection of specialty precision lab testing. The company combines...



News published on and distributed by: